亿帆医药股份有限公司关于在下属子公司之间调剂担保额度及为全资子公司提供担保的进展公告

Group 1 - The company has approved a total credit limit of up to RMB 650 million and a guarantee limit of up to RMB 600 million for itself and its subsidiaries [2][5] - The company has reallocated unused guarantee limits from subsidiaries to its wholly-owned subsidiary Hefei Yifan Pharmaceutical Co., increasing its guarantee limit from RMB 88 million to RMB 104 million [3] - As of the announcement date, the remaining guarantee balance for Hefei Yifan is RMB 93.6 million [3] Group 2 - The company signed an irrevocable maximum guarantee agreement with China Merchants Bank Hefei Branch, agreeing to provide a joint liability guarantee for Hefei Yifan's debts, with a maximum guarantee amount of RMB 10 million [4][7] - The guarantee covers loans and other credit balances within the approved credit limit, including related interest and fees [8] - The guarantee period extends until the expiration of each loan or financing agreement plus an additional three years [8] Group 3 - Hefei Yifan is a wholly-owned subsidiary of the company, established on September 9, 2022, with a registered capital of RMB 100 million [6] - The subsidiary is not listed as a dishonest executor and has stable operations, indicating its ability to repay debts [9][10] - The cumulative external guarantee balance after this new guarantee is RMB 5.132 billion, accounting for 60.22% of the company's audited net assets for 2024 [10]